Skip to main content
. 2010 Jul 14;84(19):10139–10147. doi: 10.1128/JVI.02598-09

TABLE 1.

Clinical isolates and patients' characteristics

Isolate/patient codea HAV genotypeb Hepatitis severity Age (yr) ALTc (IU/ml) Prothrombin time (%) Factor V (%) Encephalopathy Outcome
G1B1 IA Benign 37 1,455 90 NAd None Recovery
G1B2 IA Benign 43 NA 90 NA None Recovery
G1B3 IA Benign 32 924 83 NA None Recovery
G1B4 IA Benign 19 3,006 79 NA None Recovery
G1B5 IB Benign 28 NA 83 NA None Recovery
G1B6 IB Benign 17 NA 58 100 None Recovery
G1S1 IB Severe 22 6,456 18 42 None Recovery
G1F1 IA Fulminant 52 4,180 23 55 Grade 1 Recovery
G1F2 IB Fulminant 30 2,100 17 38 Grade 4 Death
G2B1 IIA Benign 46 NA NA NA None Recovery
G3B1 IIIA Benign 12 2,815 81 NA None Recovery
G3F1 IIIA Fulminant 43 3,696 8 26 Grade 1 Recovery
a

Each isolate was identified by a 4-letter code which includes the strain genotype (G1, G2, or G3 for genotype I, II, or III, respectively), the hepatitis A clinical presentation (B, S, or F for benign, severe, or fulminant, respectively), and the number of the strain.

b

HAV genotype was determined by the phylogenetic analysis of the VP1/2A junction.

c

ALT, alanine aminotransferase.

d

NA, not available.